Privacy PolicyTerms of Service
OslerMarket
K
Ask OslerLibraryLearn
OslerMarket

Filtered resources

Clinical library

444 resources

Explore a topic. Choose a collection. Find your next resource.

444 resources
Clear filters

Collections 3

Cardiology: ACS & Heart Failure16 resourcesHypertension9 resourcesECG & More17 resources

Collections

3 of 45
  • Cardiology: ACS & Heart Failure16 resourcesACS by Labu Albert · MANAGEMENT OF ACUTE CORONARY SYNDROME …
  • Hypertension9 resources2025 AHA/ACC Guideline for the Management of High Blood Pressure in Adults · ESC 2024 Hypertension Guidelines …
  • ECG & More17 resourcesAN INTRODUCTION TO THE ECG and arrythmias revision ECG Oct 2025 (2) · LITTLE BLACK BOOK OF ECG SECRETS …

Resources

24 shown
GLUCAGON-LIKE PEPTIDE-1–BASED THERAPIES IN CARDIOVASCULAR DISEASE: EVIDENCE, MECHANISMS, AND EMERGING CLINICAL APPLICATIONS coverClinical reviewsGLUCAGON-LIKE PEPTIDE-1–BASED THERAPIES IN CARDIOVASCULAR DISEASE: EVIDENCE, MECHANISMS, AND EMERGING CLINICAL APPLICATIONSDivision of Cardiology, Azienda Ospedaliero-Universitaria Policlinico ‘G. Rodolico-San Marco’, University of Catania·Cardiology· 2026· 16 pagesThis document discusses the role of glucagon-like peptide-1 (GLP-1) receptor agonists as cardiometabolic agents with cardiovascular effects, particularly in patients with type 2 diabetes and elevated cardiovascular risk.
ECHOCARDIOGRAPHY AND PULMONARY EMBOLISM coverClinical reviewsECHOCARDIOGRAPHY AND PULMONARY EMBOLISMLoyola University Medical Center, Lewis Katz School of Medicine at Temple University, Thomas Jefferson University Hospital·Cardiology· 21 pagesThis document provides a comprehensive overview of the role of echocardiography in the assessment and management of pulmonary embolism (PE), focusing on various echocardiographic parameters and their clinical implications.
FLUID RESTRICTION IN PATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEW coverClinical reviewsFLUID RESTRICTION IN PATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEWRadboud University Medical Center, Netherlands Heart Institute, Catharina Hospital, Maastricht University Medical Center, Zuyderland Medical Center, Máxima Medical Center·Cardiology· 2025· 7 pagesThis systematic review assesses the efficacy and safety of fluid restriction as a non-pharmacological intervention in the management of heart failure, highlighting recent randomized clinical trial data.
CRITERIA FOR THE DIAGNOSIS OF CARDIOGENIC SHOCK—EUROPEAN PERSPECTIVE: A CLINICAL CONSENSUS STATEMENT coverGuidelines & protocolsCRITERIA FOR THE DIAGNOSIS OF CARDIOGENIC SHOCK—EUROPEAN PERSPECTIVE: A CLINICAL CONSENSUS STATEMENTAssociation for Acute CardioVascular Care, Heart Failure Association, European Association of Percutaneous Cardiovascular Interventions·Cardiology· 15 pagesThis document presents a clinical consensus statement on the criteria for diagnosing cardiogenic shock from a European perspective, developed by various cardiovascular associations.
6
DIGITAL OUTREACH TO IMPROVE STATIN REFILLS IN PATIENTS WITH LOW STATIN ADHERENCE coverClinical reviewsDIGITAL OUTREACH TO IMPROVE STATIN REFILLS IN PATIENTS WITH LOW STATIN ADHERENCEKaiser Permanente Northern California·Cardiology· 2025· 11 pagesThis study investigates the effectiveness of a digital outreach strategy to enhance statin refill rates among patients with low adherence, particularly those with established atherosclerotic cardiovascular disease (ASCVD).
GENITOURINARY TRACT INFECTIONS AND SGLT2 INHIBITORS IN HEART FAILURE: AN EMPEROR-POOLED ANALYSIS coverClinical reviewsGENITOURINARY TRACT INFECTIONS AND SGLT2 INHIBITORS IN HEART FAILURE: AN EMPEROR-POOLED ANALYSISUniversity of Porto, Centre d'Investigations Cliniques, Baylor Scott and White Research Institute, National and Kapodistrian University of Athens, German Heart Center Charité, Baylor University Medical Center, Imperial College·Cardiology· 2026· 10 pagesThis document analyzes the relationship between sodium glucose co-transporter-2 inhibitors (SGLT2i) and the occurrence of genitourinary tract infections (UTIs) in patients with heart failure. It highlights the implications of UTIs on mortality risk and hospitalization.
DETERMINANTS OF EJECTION FRACTION IMPROVEMENT IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION coverClinical reviewsDETERMINANTS OF EJECTION FRACTION IMPROVEMENT IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTIONDepartment of Internal Medicine I, University Hospital Würzburg; Comprehensive Heart Failure Center, Würzburg, Germany·Cardiology· 14 pagesThis study investigates the prognostic value of dynamic changes in left ventricular ejection fraction (EF) for cardiovascular outcomes in heart failure patients with reduced EF. It identifies independent factors related to improvement in EF and risk factors for cardiovascular events.
A NOVEL TECHNIQUE FOR ACCESSING THE PERICARDIAL SPACE coverClinical reviewsA NOVEL TECHNIQUE FOR ACCESSING THE PERICARDIAL SPACEGuangxia Wang, Huadi Qin, Lin Hou, Xiangsen Shao, Fei Xie, Hongmei Tao, Sen Lei, Fengpeng Jia, Chunchang Qin·Cardiology· 2025· 8 pagesThis document presents an innovative wire puncture technique for pericardiocentesis aimed at enhancing safety in patients with challenging pericardial conditions. The method was tested in both animal models and clinical settings, demonstrating a high success rate.
SEMAGLUTIDE AND WALKING CAPACITY IN PEOPLE WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE AND TYPE 2 DIABETES (STRIDE): A PHASE 3B, DOUBLE-BLIND, RANDOMISED, PLACEBO CONTROLLED TRIAL coverClinical reviewsSEMAGLUTIDE AND WALKING CAPACITY IN PEOPLE WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE AND TYPE 2 DIABETES (STRIDE): A PHASE 3B, DOUBLE-BLIND, RANDOMISED, PLACEBO CONTROLLED TRIALUniversity of Colorado School of Medicine, Aurora, CO, USA·Cardiology· 2025· 14 pagesThis study evaluates the effects of semaglutide on walking ability and quality of life in individuals with symptomatic peripheral artery disease and type 2 diabetes. It is a phase 3b, double-blind, randomized, placebo-controlled trial conducted across multiple countries.
WEIGHT LOSS IN OLDER PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION coverClinical reviewsWEIGHT LOSS IN OLDER PATIENTS WITH PERSISTENT ATRIAL FIBRILLATIONnull·Cardiology· 2026· 10 pagesThis study investigates the safety and effectiveness of weight loss interventions in older patients with atrial fibrillation (AF). It focuses on whether weight loss can be beneficial without precipitating frailty in this demographic.
2024 ESC GUIDELINES FOR THE MANAGEMENT OF ELEVATED BLOOD PRESSURE AND HYPERTENSION coverGuidelines & protocols2024 ESC GUIDELINES FOR THE MANAGEMENT OF ELEVATED BLOOD PRESSURE AND HYPERTENSIONEuropean Society of Cardiology (ESC)·Cardiology· 2024· 67 pagesThese guidelines provide recommendations for the management of elevated blood pressure and hypertension, emphasizing the importance of transparency and ethical integrity in the development process.
RESISTANT HYPERTENSION: EPIDEMIOLOGY, MECHANISMS AND CONTEMPORARY THERAPEUTIC STRATEGIES coverClinical reviewsRESISTANT HYPERTENSION: EPIDEMIOLOGY, MECHANISMS AND CONTEMPORARY THERAPEUTIC STRATEGIESDepartment of Cardiology, ESIC Medical College and Hospital, Faridabad, Haryana, India; Department of Cardiology, AIIMS Bhopal, Bhopal, Madhya Pradesh, India; Department of Medicine, MGM Medical College, Indore, Madhya Pradesh, India·Cardiology· 14 pagesThis document discusses resistant hypertension (RH), a condition characterized by uncontrolled blood pressure despite treatment, and explores its epidemiology, pathophysiology, and management strategies.
CLOPIDOGREL: DRUG INFORMATION coverMedicines & prescribingCLOPIDOGREL: DRUG INFORMATIONDr. Reddys·Cardiology· 2026· 66 pagesThis document provides comprehensive drug information on Clopidogrel, including its pharmacologic category, dosing guidelines, and important alerts regarding its use in patients with specific genetic profiles.
DIAGNOSIS AND MANAGEMENT OF RESISTANT HYPERTENSION coverClinical reviewsDIAGNOSIS AND MANAGEMENT OF RESISTANT HYPERTENSIONnull·Cardiology· 12 pagesThis document is a review focusing on the diagnosis and management of resistant hypertension, which affects a significant percentage of patients treated for hypertension. It discusses the importance of recognizing true resistant hypertension and the appropriate treatment strategies.
DYS LIPIDEMIA coverClinical notesDYS LIPIDEMIADave L. Dixon, Daniel M. Riche, Michael S. Kelly·Cardiology· 11 pagesDyslipidemia is defined as elevated total cholesterol, low-density lipoprotein cholesterol, or triglycerides; low high-density lipoprotein cholesterol; or a combination of these abnormalities. This chapter discusses the clinical presentation, diagnosis, and treatment options for dyslipidemia.
HEART FAILURE TRAJECTORIES AFTER GUIDELINE-DIRECTED MEDICAL THERAPY coverClinical reviewsHEART FAILURE TRAJECTORIES AFTER GUIDELINE-DIRECTED MEDICAL THERAPYDuy Do, PhD; Karthik Murugiah, MBBS, MHS; Mitsuaki Sawano, MD, PhD; Brianna M. Goodwin Cartwright, MS; Samuel Gratzl, PhD; Lesley H. Curtis, PhD; Nicholas L. Stucky, MD, PhD·Cardiology· 4 pagesThis research letter evaluates left ventricular ejection fraction (LVEF) trajectories after guideline-directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF). It highlights the association between patient characteristics and the use of GDMT.
CHRONIC CORONARY DISEASE coverClinical notesCHRONIC CORONARY DISEASEPaul P·Cardiology· 8 pagesChronic coronary disease (CCD) is a stable form of coronary artery disease (CAD) characterized by reduced myocardial blood flow from atherosclerotic narrowing or obstruction of one or more epicardial coronary arteries.
HYPERTENSION IN ADULTS: DIAGNOSIS AND MANAGEMENT coverGuidelines & protocolsHYPERTENSION IN ADULTS: DIAGNOSIS AND MANAGEMENTNational Institute for Health and Care Excellence (NICE)·Cardiology· 2019· 52 pagesThis NICE guideline provides comprehensive recommendations for the diagnosis and management of hypertension in adults, emphasizing the importance of individualized patient care.
CHAPTER 12: HYPERTENSION coverClinical notesCHAPTER 12: HYPERTENSIONEric J·Cardiology· 14 pagesThis chapter discusses hypertension, including its classification, clinical presentation, and management strategies based on the latest guidelines.
CORONARY PLAQUE PROGRESSION AFTER ANDROGEN DEPRIVATION THERAPY IN MEN WITH PROSTATE CANCER coverClinical reviewsCORONARY PLAQUE PROGRESSION AFTER ANDROGEN DEPRIVATION THERAPY IN MEN WITH PROSTATE CANCERnull·Cardiology· 5 pagesThis randomized clinical trial investigates the association between androgen deprivation therapy (ADT) and accelerated coronary atherosclerosis in men with prostate cancer, comparing the effects of GnRH agonists and antagonists.
SACUBITRIL AND VALSARTAN: DRUG INFORMATION coverMedicines & prescribingSACUBITRIL AND VALSARTAN: DRUG INFORMATIONUpToDate, Inc.·Cardiology· 2026· 40 pagesThis document provides comprehensive drug information on sacubitril and valsartan, including dosing guidelines, pharmacologic categories, and safety warnings, particularly regarding fetal toxicity.
MANAGEMENT OF ACUTE CORONARY SYNDROME coverGuidelines & protocolsMANAGEMENT OF ACUTE CORONARY SYNDROMEAmerican College of Cardiology (ACC), American Heart Association (AHA), American College of Emergency Physicians (ACEP), National Association of EMS Physicians (NAEMSP), Society for Cardiovascular Angiography and Interventions (SCAI)·Cardiology· 2025· 2 pagesThis document provides clinical guidelines for the management of patients with acute coronary syndrome (ACS), detailing recommendations for treatment and interventions.
1
CORONARY ARTERY CALCIUM IN ACC/AHA PREVENTION GUIDELINES coverClinical reviewsCORONARY ARTERY CALCIUM IN ACC/AHA PREVENTION GUIDELINESKyvan Irannejad, MD, Ruben Mora, MD, Srikanth Krishnan, MD, Suvasini Lakshmanan, MD, Sion Roy, MD, Matthew J. Budoff, MD·Cardiology· 2026· 5 pagesThis editorial viewpoint discusses the evolution of coronary artery calcium (CAC) scoring in cardiovascular risk stratification as reflected in the ACC/AHA prevention guidelines from 2007 to 2026.
HEART FAILURE coverClinical notesHEART FAILUREJo E·Cardiology· 12 pagesThis chapter provides a comprehensive overview of heart failure (HF), including its definitions, clinical presentations, diagnosis, and management strategies.
PreviousPage 12 of 19Next

© 2026 Osler Market

Library·Ask Osler·Learn·Terms·Privacy·Support·WhatsApp Channel

For learning purposes. Always consult clinical guidelines.

Ask OslerLibraryLearn
HomeAskLibraryLearnAccount